| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $991.0M | — | +10.5% |
| Cost of Revenue | $675.0M | — | +17.0% |
| R&D Expense | $28.0M | — | +27.3% |
| SG&A Expense | $108.0M | — | +16.1% |
| Pre-tax Income | $136.0M | — | -27.7% |
| Income Tax | $31.0M | — | -34.0% |
| Net Income | $85.0M | — | -36.6% |
| EPS (Basic) | $0.53 | — | -37.6% |
| EPS (Diluted) | $0.53 | — | -37.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $642.0M | +20.2% | — |
| Accounts Receivable | $632.0M | -2.0% | — |
| Inventory | $704.0M | -1.5% | — |
| Current Assets | $2.44B | +2.0% | — |
| Total Assets | $5.75B | +1.3% | — |
| Current Liabilities | $1.71B | -0.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $199.0M | — | +24.4% |
| Capital Expenditures | $75.0M | — | +21.0% |
| Investing Cash Flow | -$77.0M | — | -97.4% |
| Financing Cash Flow | -$15.0M | — | +87.3% |
| Free Cash Flow | $124.0M | — | +26.5% |
| Long-term Debt | $1.97B | -1.8% | — |
| Total Liabilities | $4.28B | -0.5% | — |
| Stockholders' Equity | $1.49B | +5.3% | -54.0% |